Drug profile · INN
azilsartan medoxomil
EDARBI
- US status
- approved
- Patents linked
- 1
- News articles
- 0
Quick answer
azilsartan medoxomil (EDARBI) is an FDA-listed pharmaceutical active ingredient. Associated with Takeda Pharmaceuticals International AG. Current US regulatory status: approved.
Key facts
INN azilsartan medoxomil
Brand EDARBI
Formulation TABLET
ATC code C09CA09
Originator Takeda Pharmaceuticals International AG
Related patents
Search patents →Frequently asked questions
What is azilsartan medoxomil?
azilsartan medoxomil (EDARBI) is an FDA-listed pharmaceutical active ingredient. Associated with Takeda Pharmaceuticals International AG. Current US regulatory status: approved.
What is the brand name for azilsartan medoxomil?
EDARBI is a marketed brand name for azilsartan medoxomil. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of azilsartan medoxomil?
azilsartan medoxomil has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.